⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors

Official Title: A Phase I Dose Escalation Study of NMS-1286937 Administered to Adult Patients With Advanced/Metastatic Solid Tumors

Study ID: NCT01014429

Interventions

NMS-1286937

Study Description

Brief Summary: The purpose of this study is to evaluate the safety and tolerability of NMS-1286937, a polo-like-kinase 1 inhibitor, in patients with advanced metastatic solid tumor.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Arizona TGen Clinical Research Services at Scottsdale Heathcare, Scottsdale, Arizona, United States

Contact Details

Name: Mariangela Mariani, Biol Sci D

Affiliation: Nerviano Medical Sciences

Role: STUDY_DIRECTOR

Name: Maria Adele Pacciarini, Biol Sci D

Affiliation: Nerviano Medical Sciences

Role: STUDY_DIRECTOR

Name: Glen J Weiss, MD

Affiliation: Arizona TGen Clinical Reserch Services at Scottsdale Healthcare

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: